What does CUSIP 868459108 represent in this 13F holders report?

CUSIP 868459108 is the security identifier for SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in Q1 2016?

209 institutional investors reported SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock for Q1 2016. Use the holders table for investor-level position and value details.

SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)

CUSIP: 868459108

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class: Equity / Common Stock
Shares outstanding: 57,572,193
Total 13F shares: 44,933,850
Share change: +342,529
Total reported value: $685,195,121
Put/Call ratio: 33%
Price per share: $15.25
Number of holders: 209
Value change: +$7,308,210
Number of buys: 111
Number of sells: 105

Quarterly Holders Quick Answers

What is CUSIP 868459108?
CUSIP 868459108 identifies SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2016
Previous quarter: Q4 2015

Recent filing periods for CUSIP 868459108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Fund Advisors	13F	Company	4.9%	2,795,751	$37,575,000	—	31 Dec 2015	13F
Ranger Investment Management, L.P.	13F	Company	3.4%	1,984,978	$26,678,000	—	31 Dec 2015	13F
GLENMEDE TRUST CO NA	13F	Company	3.3%	1,895,663	$25,476,000	—	31 Dec 2015	13F
VANGUARD GROUP INC	13F	Company	3%	1,720,166	$23,119,000	—	31 Dec 2015	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	2.8%	1,632,683	$21,940,000	—	31 Dec 2015	13F
Invesco Ltd.	13F	Company	2.8%	1,618,250	$21,749,000	—	31 Dec 2015	13F
Apex Capital Management	13F	Company	2.5%	1,424,426	$19,144,000	—	31 Dec 2015	13F
STATE STREET CORP	13F	Company	2.3%	1,313,191	$17,653,000	—	31 Dec 2015	13F
KORNITZER CAPITAL MANAGEMENT INC /KS	13F	Company	2.2%	1,245,170	$16,735,000	—	31 Dec 2015	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.9%	1,087,055	$14,610,000	—	31 Dec 2015	13F
Atle Fund Management AB	13F	Company	1.8%	1,051,277	$14,129,000	—	31 Dec 2015	13F
Michael R. Murphy	13F	Individual	1.6%	920,550	$12,372,000	—	31 Dec 2015	13F
NEUMEIER POMA INVESTMENT COUNSEL LLC	13F	Company	1.6%	901,330	$12,114,000	—	31 Dec 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.5%	873,768	$11,743,000	—	31 Dec 2015	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.3%	743,441	$9,992,000	—	31 Dec 2015	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	1.2%	663,749	$8,921,000	—	31 Dec 2015	13F
RUSSELL FRANK CO/	13F	Company	1.1%	648,277	$8,871,000	—	31 Dec 2015	13F
Allianz Asset Management GmbH	13F	Company	1.1%	656,116	$8,818,000	—	31 Dec 2015	13F
NORTHPOINTE CAPITAL LLC	13F	Company	1%	584,753	$8,204,000	—	31 Dec 2015	13F
Bank of New York Mellon Corp	13F	Company	1.1%	608,894	$8,183,000	—	31 Dec 2015	13F
MORGAN STANLEY	13F	Company	1%	576,093	$7,742,000	—	31 Dec 2015	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	0.94%	539,228	$7,247,000	—	31 Dec 2015	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.9%	516,784	$6,945,000	—	31 Dec 2015	13F
ASHFORD CAPITAL MANAGEMENT INC	13F	Company	0.88%	509,244	$6,844,000	—	31 Dec 2015	13F
TEACHERS ADVISORS, LLC	13F	Company	0.88%	504,095	$6,775,000	—	31 Dec 2015	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.87%	498,000	$6,693,000	—	31 Dec 2015	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.83%	478,430	$6,430,000	—	31 Dec 2015	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.83%	477,068	$6,412,000	—	31 Dec 2015	13F
FMR LLC	13F	Company	0.76%	438,700	$5,896,000	—	31 Dec 2015	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.74%	424,712	$5,708,000	—	31 Dec 2015	13F
Opaleye Management Inc.	13F	Company	0.73%	420,000	$5,645,000	—	31 Dec 2015	13F
Skandinaviska Enskilda Banken AB (publ)	13F	Company	0.71%	408,700	$5,493,000	—	31 Dec 2015	13F
NORTHERN TRUST CORP	13F	Company	0.7%	403,603	$5,424,000	—	31 Dec 2015	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.68%	390,994	$5,351,000	—	31 Dec 2015	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.68%	392,922	$5,280,000	—	31 Dec 2015	13F
MCKINLEY CAPITAL MANAGEMENT LLC	13F	Company	0.63%	364,794	$4,903,000	—	31 Dec 2015	13F
Bellevue Asset Management AG	13F	Company	0.62%	355,000	$4,771,000	—	31 Dec 2015	13F
Hodges Capital Management Inc.	13F	Company	0.57%	330,380	$4,440,000	—	31 Dec 2015	13F
CITADEL ADVISORS LLC	13F	Company	0.55%	316,011	$4,247,000	—	31 Dec 2015	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.54%	313,091	$4,208,000	—	31 Dec 2015	13F
FALCON POINT CAPITAL, LLC	13F	Company	0.53%	304,603	$4,094,000	—	31 Dec 2015	13F
Rhenman & Partners Asset Management AB	13F	Company	0.5%	288,000	$3,871,000	—	31 Dec 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.5%	285,959	$3,843,000	—	31 Dec 2015	13F
STRS OHIO	13F	Company	0.49%	283,640	$3,812,000	—	31 Dec 2015	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.48%	275,877	$3,708,000	—	31 Dec 2015	13F
HARBOURVEST PARTNERS LLC	13F	Company	0.48%	275,753	$3,706,000	—	31 Dec 2015	13F
CASTLEARK MANAGEMENT LLC	13F	Company	0.45%	259,272	$3,485,000	—	31 Dec 2015	13F
Bruce & Co., Inc.	13F	Company	0.44%	254,581	$3,421,000	—	31 Dec 2015	13F
EverPoint Asset Management, LLC	13F	Company	0.43%	250,000	$3,360,000	—	31 Dec 2015	13F
AlphaOne Investment Services, LLC	13F	Company	0.42%	240,043	$3,225,000	—	31 Dec 2015	13F

Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q1 2016

As of 31 Mar 2016, SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) was held by 209 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,933,850 shares. The largest 10 holders included BlackRock Fund Advisors, Ranger Investment Management, L.P., GLENMEDE TRUST CO NA, VANGUARD GROUP INC, Apex Capital Management, ACADIAN ASSET MANAGEMENT LLC, FMR LLC, Bank of New York Mellon Corp, Invesco Ltd., and Neumeier Poma Investment Counsel LLC. This page lists 209 institutional shareholders reporting positions in this security for the Q1 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2016 vs Q4 2015 Across Filers

Q4 2015 holders

205

Q1 2016 holders

209

Holder diff

Investor	Q4 2015 Shares	Q1 2016 Shares	Share Diff	Share Chg %	Q4 2015 Value $	Q1 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.